Former Bellator middleweight champion Alexander Shlemenko (52-9) has tested positive for an elevated testosterone-to-epitestosterone ratio and will soon be suspended by the California State Athletic Commission.

MMAjunkie today confirmed with multiple sources close to the Russian fighter that Shlemenko failed his post-fight test following a Feb. 13 win over Melvin Manhoef at Bellator 133, which took place at Save Mart Center in Fresno, Calif.

The sources spoke on the condition of anonymity because they are not authorized to publicly discuss such matter.

CSAC officials weren’t immediately available for comment, but a Bellator representative confirmed the failed test, and Bellator MMA President Scott Coker did issue a brief statement to MMAjunkie.

“We are disappointed to hear about the results of Shlemenko’s drug test,” Coker stated. “As I’ve stated previously, performance enhancing drugs have no place in this sport, and Bellator fully supports the commission in enforcing harsh penalties to deter fighters from taking banned substances.”

Shlemenko’s exact testosterone-to-epitestosterone ratio wasn’t immediately available, but the sources suggested there was a “significantly elevated” level.

CSAC officials will announce disciplinary plans for Shlemenko at a later date, and the result of the bout is expected to be overturned to a no contest.

Shlemenko’s second-round spinning backfist knockout of Manhoef was voted MMAjunkie’s “Knockout of the Month” for February, both by staff and fans.

For additional coverage of Bellator 133, check out the MMA Events section of the site.